Company profile: Girindus
1.1 - Company Overview
Company description
- Provider of solid-phase oligonucleotide manufacturing and customer-driven services for pharmaceutical clients, including process development, analytical method development, radiolabeling, cGMP-compliant scale-up, active ingredient manufacturing, and regulatory support, with expertise in both oligonucleotide and small molecule.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Girindus
Adalvo
HQ: Malta
Website
- Description: Provider of B2B pharmaceutical products and services, part of Alvogen Group and powered by Alvogen and Alvotech. Offers 90+ specialty generic small-molecule products across Oncology, Women’s Health, Cardiovascular and CNS; 15+ value-added 505(b)(2) CNS therapies; and 8+ peptide products for Rare Diseases and Diabetes. Develops Fidaxomicin 200 mg tablets, Ethinylestradiol/Drospirenone, and Dimethyl Fumarate for RRMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adalvo company profile →
Aptuit
HQ: United States
Website
- Description: Provider of integrated CRO/CDMO services spanning early discovery to mid-phase drug development, including drug design and discovery, API development and manufacture, solid state chemistry, CMC, preclinical, and IND-enabling GLP/GMP programs. Offers an AI-powered PanOmics platform, iPSC-based disease modeling, molecular glue degraders, neuroscience drug discovery, and biosimilar development via a partnership with Sandoz.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptuit company profile →
Evergreen Theragnostics
HQ: United States
Website
- Description: Provider of radiopharmaceutical contract development and manufacturing services, covering early-stage development through commercial production. The company develops and commercializes radiopharmaceuticals (e.g., Ga-68 DOTATOC), discovers novel radiopharmaceuticals for unmet clinical needs in cancer treatment, and operates an Alpha Therapy Line for GMP Ac-225 products and a Springfield facility compliant with US FDA 21 CFR 211 and EMA cGMP.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evergreen Theragnostics company profile →
NorthX Biologics
HQ: Sweden
Website
- Description: Provider of contract development and manufacturing services for biologics from concept to commercial manufacturing; process development upstream/downstream optimization and verification; biopharmaceutical testing (analytical development, method validation, stability); recombinant protein production (microbial and mammalian); viral vector and vaccine development/manufacturing for clinical and commercial stages; GMP/non-GMP plasmid DNA production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthX Biologics company profile →
Red Nucleus
HQ: United States
Website
- Description: Provider of award-winning e-learning, digital content, and performance solutions for the Life Sciences industry, specializing in professional training, marketing learning systems, and workshops that engage client-facing teams throughout their continuing education journey, with offices in the US, UK, and India.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Red Nucleus company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Girindus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Girindus
2.2 - Growth funds investing in similar companies to Girindus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Girindus
4.2 - Public trading comparable groups for Girindus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →